A new study is helping to clarify how low-grade lymphoma changes as it develops into a more aggressive tumor, which could lead to the development of new treatments.
An expanding artificial heart valve being developed by Columbia surgeons and engineers could simplify treatment for many kids born with congenital heart disease.
Columbia researchers discovered stem cells in mice that are essential in maintaining healthy cartilage inside joints, but the cells go missing with age or after injury.
Many Black Americans thought to have a high risk of developing kidney disease possess a genetic variant that eradicates the extra risk, a new study from Columbia researchers has found.
Immunotherapy has been disappointing as treatment for prostate cancer, but a new Columbia trial suggests it has potential for treating metastatic disease.
Columbia physicians and patients were essential in demonstrating the effectiveness of the world’s first CRISPR gene-editing therapy, now approved for use in the United States.
Dr. Monica Bhatia is Johnny's doctor and the chief of pediatric stem cell transplantation at NewYork-Presbyterian/Columbia University Irving Medical Center.
